Outset Medical, Inc. (NASDAQ:OM) General Counsel Sells $26,344.00 in Stock

Outset Medical, Inc. (NASDAQ:OM) General Counsel John L. Brottem sold 32,930 shares of the firm’s stock in a transaction that occurred on Tuesday, January 21st. The stock was sold at an average price of $0.80, for a total value of $26,344.00. Following the transaction, the general counsel now owns 181,188 shares of the company’s stock, valued at $144,950.40. This trade represents a 15.38 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Outset Medical Stock Performance

NASDAQ OM opened at $0.86 on Friday. Outset Medical, Inc. has a 1-year low of $0.44 and a 1-year high of $5.22. The company has a 50 day moving average of $1.01 and a 200-day moving average of $1.28. The company has a current ratio of 6.49, a quick ratio of 5.04 and a debt-to-equity ratio of 4.12. The firm has a market cap of $45.18 million, a price-to-earnings ratio of -0.31 and a beta of 2.05.

Wall Street Analyst Weigh In

Separately, Royal Bank of Canada reiterated a “sector perform” rating and set a $3.00 price objective on shares of Outset Medical in a research note on Tuesday, January 7th.

Institutional Investors Weigh In On Outset Medical

A number of hedge funds and other institutional investors have recently bought and sold shares of OM. National Bank of Canada FI boosted its stake in Outset Medical by 79.2% in the third quarter. National Bank of Canada FI now owns 52,407 shares of the company’s stock worth $35,000 after purchasing an additional 23,164 shares in the last quarter. Huntington National Bank increased its stake in shares of Outset Medical by 46.2% in the third quarter. Huntington National Bank now owns 63,306 shares of the company’s stock valued at $43,000 after buying an additional 20,000 shares in the last quarter. Vanguard Personalized Indexing Management LLC bought a new position in shares of Outset Medical in the second quarter valued at about $49,000. Point72 Asia Singapore Pte. Ltd. acquired a new position in Outset Medical during the 2nd quarter worth about $259,000. Finally, Squarepoint Ops LLC grew its holdings in Outset Medical by 74.1% during the 2nd quarter. Squarepoint Ops LLC now owns 80,300 shares of the company’s stock worth $309,000 after acquiring an additional 34,187 shares during the last quarter.

About Outset Medical

Outset Medical, Inc, a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.